Pereiti į pagrindinį turinį
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Albania | English
Albania | Shqip
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Albania | English
Albania | Shqip
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • Apie mus 
      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus
      Apie mus
    • Pacientai ir slaugytojai 
      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Ligos 
        • Dislipidemija 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 
        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 
      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje
      Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 
      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 
        • Etikos kodeksas 
      Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV)
      Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV)
    • Naujienos 
      • Naujienų archyvas 
      • Susisiekite su mumis 
      A photo of people in a meeting hall
      Naujienos
    • Karjera 
      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera
      Karjera
    • Koronavirusas 
      Koronavirusas
      Koronavirusas
    Lietuvos ofisas
    Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjeros paieška
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas Sort ascending
  • Svetainė
  • Vieta
  • Padalinys
  • Veikla
  • Functional Area
  • Paskelbimo data
Darbo pavadinimas Sort ascending Svetainė Vieta Padalinys Veikla Functional Area Paskelbimo data
Medical Science Liaison 本社 Japan International Marketing Research & Development Lap 08, 2026
Medical Science Liaison 本社 Japan International Other Research & Development Lap 08, 2026
SSO Study Start-Up Manager 本社 Japan Development Development Research & Development Lap 09, 2026
Medical Science Liaison 本社 Japan International Marketing Research & Development Lap 10, 2026
SSO Associate Clinical Project Manager 本社 Japan Development Development Research & Development Lap 10, 2026
Japan Program Manager 本社 Japan Development Development Research & Development Rgs 08, 2026
Associate or Manager, PHAD Japan 本社 Japan Development Development Research & Development Spl 26, 2026
Principal Scientist II (Lab Head), Allergy and Plasma Cell Research Basel (City) Switzerland Biomedical Research Research Research & Development Lap 05, 2026
Evidence Manager Taipei Taiwan International Development Research & Development Lap 05, 2026
Robotics Engineer (m/f/d) Basel (City) Switzerland Development Development Research & Development Lap 05, 2026
Expert Engineering (m/f/d) Schaftenau Austria Development Development Research & Development Lap 05, 2026
Senior Expert Engineering (m/f/d) Schaftenau Austria Development Development Research & Development Lap 05, 2026
Medical Information Agent INSURGENTES Mexico US Marketing Research & Development Kov 31, 2026
Head, TCO (Translational Clinical Oncology) China Shanghai (Shanghai) China Biomedical Research Research Research & Development Bal 28, 2026
PK Director (临床药理总监) Shanghai (Shanghai) China Biomedical Research Research Research & Development Bir 22, 2026
Director, Preclinical Safety (Toxicology) China Head Shanghai (Shanghai) China Biomedical Research Research Research & Development Bir 22, 2026
Associate Director, PK Scientist/Clinical pharmacologist Shanghai (Shanghai) China Biomedical Research Research Research & Development Bir 22, 2026
Early Clinical Development Physician (Oncology) Shanghai (Shanghai) China Biomedical Research Research Research & Development Bir 22, 2026
Principal Scientist I Cambridge (USA) USA Biomedical Research Research Research & Development Bir 22, 2026
Senior Expert Engineering Device Development Schaftenau Austria Development Development Research & Development Bir 17, 2026
Medical Science Liaison (MSL) – Neuromuscular (WA, OR) Remote Field Non-Sales (USA) USA US Marketing Research & Development Bir 22, 2026
Associate Director, Statistical Programming London (The Westworks) United Kingdom Development Development Research & Development Bir 22, 2026
Medical Advisor -BC Shanghai (Shanghai) China International Development Research & Development Bir 25, 2026
Principal Scientist II/Senior Principal Scientist, PK Sciences Clinical Pharmacology Artificial Intelligence (AI) Lead (dual level posting) Cambridge (USA) USA Biomedical Research Research Research & Development Bir 26, 2026
Japan Program Clinical Head (CRM) Toranomon (NPKK Head Office) Japan Development Development Research & Development Lie 05, 2026
Principal Scientist II - Pharmacology Cambridge (USA) USA Biomedical Research Research Research & Development Lie 09, 2026
Clinical Data Domain Owner Basel (City) Switzerland Biomedical Research Research Research & Development Lap 20, 2026
Associate Director, ADC platform in Oncology Drug Discovery Cambridge (USA) USA Biomedical Research Research Research & Development Lap 20, 2026
MSL ONCOLOGY INSURGENTES Mexico International Development Research & Development Lap 20, 2026
Principal Scientist II Cambridge (USA) USA Biomedical Research Research Research & Development Lap 20, 2026
Principal Scientist I/II for Multi-specific biologics in Oncology Drug Discovery Cambridge (USA) USA Biomedical Research Research Research & Development Lap 20, 2026
Quality Control Analyst Ivrea Italy Development Development Research & Development Lap 18, 2026
Development Regulatory Affaires (開発薬事) - Neuroscience, Gene Therapy & Precision Diagnostics 本社 Japan Development Development Research & Development Bir 22, 2026
Evidence Generation Manager (Maternity Cover) Milano Italy International Development Research & Development Spl 29, 2026
Managed Access Program Manager - maternity leave Milano Italy International Development Research & Development Spl 29, 2026
Medical Science Liaison Moscow (City) Russian Fed. International General Management Research & Development Lap 17, 2026
Principal Scientist I/II, BMD Shanghai (Shanghai) China Biomedical Research Research Research & Development Rgs 29, 2026
Principal Scientist – Analytics Team Lead Cambridge (USA) USA Biomedical Research Research Research & Development Spl 04, 2026
Senior Principal Biostatistician London (The Westworks) United Kingdom Development Development Research & Development Spl 05, 2026
in vivo Senior Scientist, Comparative Medicine Cambridge (USA) USA Biomedical Research Research Research & Development Spl 05, 2026
Medical AI Strategy & Ecosystem Partnership Lead Shanghai (Shanghai) China International Development Research & Development Spl 08, 2026
Associate Director Science & Technology Changshu (Jiangsu Province) China Development Development Research & Development Spl 13, 2026
(Senior) Manager, Regulatory Policy & Intelligence Beijing (Beijing) China Development Development Research & Development Spl 14, 2026
Senior Expert Engineering Ivrea Italy Development Development Research & Development Spl 14, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development Spl 26, 2026
Medical Science Liaison- PC Tianjin (Tianjin) China International Development Research & Development Spl 26, 2026
Launch and Scientific Operation Lead, Medical Shanghai (Shanghai) China International Development Research & Development Spl 27, 2026
Senior Principal, Statistical Programmer London (The Westworks) United Kingdom Development Development Research & Development Spl 27, 2026
Senior Expert, Material Science Project Leader Hyderabad (Office) India Development Development Research & Development Spl 27, 2026
Senior Analytical Expert Science & Technology (m/f/d) Mengeš Slovenia Development Development Research & Development Spl 28, 2026

Pagination

  • ‹ Ankstesnis puslapis
  • 1
  • 2
  • 3
  • 4
  • › Next page
No matching countries found
Paieška

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas
Mūsų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė
  • Svetainė sveikatos priežiūros specialistams
Footer Bottom
© 2026 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas
Novartis svetainių katalogas
Ši svetainė skirta Lietuvos gyventojams